tiprankstipranks
Tianjin Development: Lisheng Plans Share Repurchase and Awards
Company Announcements

Tianjin Development: Lisheng Plans Share Repurchase and Awards

Tianjin Development Holdings (HK:0882) has released an update.

Don't Miss Our Christmas Offers:

Tianjin Development Holdings’ subsidiary, Lisheng Pharmaceutical, has announced plans for a significant share repurchase program and a share award scheme. The repurchase program aims to buy back shares worth between RMB76.5 million and RMB153 million, while the award scheme will distribute restricted shares to key management. These moves are part of strategic maneuvers in the market and are subject to shareholder approval.

For further insights into HK:0882 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskTianjin Development Secures HK$100 Million Loan Facility
TipRanks HongKong Auto-Generated NewsdeskTianjin Development’s Strategic Agreements Set for Approval
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App